Director, Life Sciences Institute, University of Michigan
Chief Strategy and Innovation Officer, Blue Cross and Blue Shield of North Carolina
Nobel Laureate, Professor of Biology, Caltech
CEO and Fund Manager, Renaissance Venture Capital Fund
An estimated two-thirds of all Americans are currently overweight, and U.S. health agencies estimate that 25 million people have Type 2 diabetes—and an estimated one-third of the U.S. population could have diabetes by the year 2050. It’s becoming an epidemic of diabetes and obesity—or diabesity. San Diego’s biotech cluster happens to have core strength in this field, from well-known public companies like Amylin Pharmaceuticals, Orexigen Therapeutics, and Arena Pharmaceuticals to a new wave of startups. Xconomy has recruited CEOs and other leaders in the field to discuss their efforts to help the U.S. better manage this long-term threat to public health and wellbeing.
Registration: 5:15 – 6:00 pm
Program: 6:00 – 7:15 pm
Networking: 7:15 – 8:15 pm
Early Bird Rate (ends Jan. 6): $75.00
Startup Special: $65.00
For employees of startups less than 3 years old with 20 or fewer employees.
Regular Registration: $95.00
Student Registration: $20.00
Limited number available. Valid student ID must be shown at registration desk.
Walk-in Registration: $125.00